Parkinson’s disease is a type of neurological disorder primarily affecting movement. It is caused by a loss of cells in the part of the brain known as the Substantia nigra. These cells produce a chemical known as dopamine, which helps with the regulation of motor functions. As more cells are lost, symptoms of Parkinson’s begin to appear, usually in older adults. Typical symptoms include tremor, rigidity, slow and unsteady movements, and changes in the person’s gait, posture, and balance. Other symptoms can include speech problems and difficulties with memory and cognition. The cause of Parkinson’s is not known for certain, although some genetic factors may increase vulnerability to the condition. It can sometimes be triggered by environmental factors, such as certain medications or exposure to toxins. The main treatments for Parkinson’s are medications, physical therapy, occupational therapy, and surgery. Medication can help improve the symptoms, while physical and occupational therapy can help the person maintain strength and balance. Surgery may be recommended to alleviate the symptoms of Parkinson’s, such as deep brain stimulation (DBS). It is also important to note that lifestyle changes may help improve the quality of life for those with Parkinson’s. This includes exercise, a healthy diet, rest, good sleep habits, stress management, and support from family and friends. Although Parkinson’s is a serious condition, with early diagnosis, treatments can be successful in slowing the progression and effectively managing symptoms. As research progresses, new treatments and therapies are continually being developed, allowing those with Parkinson's to lead a better quality of life.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom